Share:
Original Article

Prevalence of Atherosclerosis in Psoriatic Patients Detected with Epiaortic Color Doppler Ultrasound and Computed Tomography Angiography

Author Affiliation(s)

Abstract

Introduction: Psoriasis (PsO), a chronic inflammatory, multisystemic, and multifactorial disease can cause endothelial dysfunction, artery calcification, and atherosclerotic disease. A higher incidence of vascular occlusive events has been observed in psoriatic patients compared to healthy controls, and multiple studies confirm the association between moderate-severe PsO and atherosclerosis, coronary artery calcification, and higher cardiovascular risk.


Objective: We sought to analyze atherosclerotic disease prevalence in epiaortic vessels of psoriatic and non-psoriatic patients to understand if PsO could represent an independent risk factor predisposing to atherosclerotic disease.


Methods: We evaluated 47 psoriatic patients without cardiovascular risk factors with color Doppler ultrasound (CDUS). If atheromatous plaques were detected, a computed tomography angiography (CTA) was performed. We evaluated 47 non-psoriatic patients without cardiovascular risk factors with CDUS. Atherosclerosis prevalence in both groups were statistically analyzed. CDUS performance was compared to CTA.


Results: In the psoriatic group (mean age 50.9 years), 6 had atheromatous plaques and 12 had an intima-media thickness (IMT) > 1 mm (overall prevalence of atherosclerotic disease: 38.2%). All plaques detected with CDUS were confirmed at CTA. In the control group (mean age 51.3 years), CDUS revealed atheromatous plaques in 4 patients and IMT > 1 mm in 4 ones (overall prevalence of 17%). The difference of atherosclerotic disease prevalence between the groups was statistically significant (P < 0.05).


Conclusion: Our results highlight that PsO could be considered a predisposing factor for atherosclerotic disease development in epiaortic vessels, as it causes an increased IMT, that is also considered an independent cardiovascular risk factor.

Keywords : psoriasis, color-Doppler Ultrasound, Angio-CT; IMT; risk-factor

References

1. Dattola A, Cannizzaro MV, Mazzeo M, Bianchi L.. Certolizumab Pegol in the Treatment of Psoriasis and Psoriatic Arthritis: Preliminary Real-Life Data. Dermatol Ther (Heidelb). 2017;7(4):485-492. DOI: 10.1007/s13555-017-0208-z. PMID: 29139035; PMCID: PMC5698207. 2. Boehncke S, Thaci D, Beschmann H, et al. Psoriasis patients show signs of insulin resistance. Br J Dermatol. 2007;157(6):1249-1251. DOI: 10.1111/j.1365-2133.2007.08190.x. PMID: 17916217. 3. McDonald CJ, Calabresi P. Psoriasis and occlusive vascular disease. Br J Dermatol. 1978;99(5):469-745. DOI: 10.1111/j.1365-2133.1978.tb02012.x. PMID: 708620. 4. Abuabara K, Azfar RS, Shin DB, Neimann AL, Troxel AB, Gelfand JM. Cause-specific mortality in patients with severe psoriasis: a population-based cohort study in the U.K. Br J Dermatol. 2010;163(3):586-592. DOI: 10.1111/j.1365-2133.2010.09941.x. PMID: 20633008; PMCID: PMC2966545 5. .Ahlehoff O. Gislason GH, Jørgensen CH, et al. Psoriasis and risk of atrial fibrillation and ischaemic stroke: a Danish Nationwide Cohort Study. Br J Dermatol. 2007;157(6):1249-5121. DOI: 10.1111/j.1365-2133.2007.08190.x. PMID: 17916217. 6. Mehta NN, Yu Y, Pinnelas R, et al. Attributable risk estimate of severe psoriasis on major cardiovascular events. Am J Med. 2011;124(8):775.e1-6. DOI: 10.1016/j.amjmed.2011.03.028. PMID: 21787906; PMCID: PMC3146037. 7. Ludwig RJ, Herzog C, Rostock A, et al. Psoriasis: a possible risk factor for development of coronary artery calcification. Br J Dermatol. 2007;156(2):271-276. DOI: 10.1111/j.1365-2133.2006.07562.x. PMID: 17223866.. 8. Brauchli YB, Jick SS, Miret M, Meier CR. Psoriasis and risk of incident myocardial infarction, stroke or transient ischaemic attack: an inception cohort study with a nested case-control analysis. Br J Dermatol. 2009;160(5):1048-1056. DOI: 10.1111/j.1365-2133.2008.09020.x. PMID: 19210501. 9. Gelfand JM, Neimann AL, Shin DB, Wang X, Margolis DJ, Troxel AB. Risk of myocardial infarction in patients with psoriasis. JAMA. 2006 ;296(14):1735-1741. DOI: 10.1001/jama.296.14.1735. PMID: 17032986. 10. Mallbris L, Akre O, Granath F, et al.. Increased risk for cardiovascular mortality in psoriasis inpatients but not in outpatients. Eur J Epidemiol. 2004;19(3):225-230. DOI: 10.1023/b:ejep.0000020447.59150.f9. PMID: 15117115. 11. Prodanovich S, Kirsner RS, Kravetz JD, Ma F, Martinez L, Federman DG. Association of psoriasis with coronary artery, cerebrovascular, and peripheral vascular diseases and mortality. Arch Dermatol. 2009 Jun;145(6):700-703. DOI: 10.1001/archdermatol.2009.94. PMID: 19528427. 12. Gisondi P, Tessari G, Conti A, et al. Prevalence of metabolic syndrome in patients with psoriasis: a hospital-based case-control study. Br J Dermatol. 2007;157(1):68-73. DOI: 10.1111/j.1365-2133.2007.07986.x. Epub 2007 Jun 6. PMID: 17553036. 13. Mehta NN, Azfar RS, Shin DB, Neimann AL, Troxel AB, Gelfand JM. Patients with severe psoriasis are at increased risk of cardiovascular mortality: cohort study using the General Practice Research Database. Eur Heart J. 2010;31(8):1000-1006. DOI: 10.1093/eurheartj/ehp567. PMID: 20037179; PMCID: PMC2894736. 14. Anzidei M, Napoli A, Zaccagna F, et al. Diagnostic Accuracy of Colour Doppler Ultrasonography, CT Angiography and Blood-Pool-Enhanced MR Angiography in Assessing Carotid Stenosis: A Comparative Study With DSA in 170 Patients. Radiol Med. 2012 Feb;117(1):54-71. DOI: 10.1007/s11547-011-0651-3. PMID: 21424318. 15. Johri AM, Nambi V, Naqvi TZ, et al. Recommendations for the Assessment of Carotid Arterial Plaque by Ultrasound for the Characterization of Atherosclerosis and Evaluation of Cardiovascular Risk: From the American Society of Echocardiography. J Am Soc Echocardiogr. 2020;33(8):917-933. DOI: 10.1016/j.echo.2020.04.021. PMID: 32600741. 16. Saba L, Mallarini GA. A comparison between NASCET and ECST methods in the study of carotids: evaluation using Multi-Detector-Row CT angiography. Eur J Radiol. 2010;76(1):42-47. DOI: 10.1016/j.ejrad.2009.04.064. PMID: 19464837. 17. Ikäheimo I, Tiilikainen A, Karvonen J, Silvennoinen-Kassinen S. HLA risk haplotype Cw6,DR7,DQA1*0201 and HLA-Cw6 with reference to the clinical picture of psoriasis vulgaris. Arch Dermatol Res. 1996;288(7):363-365. DOI: 10.1007/BF02507104. PMID: 8818183. 18. Meijer K, de Vries M, Al-Lahham S, et al. Human primary adipocytes exhibit immune cell function: adipocytes prime inflammation independent of macrophages. PLoS One. 2011;6(3):e17154. DOI: 10.1371/journal.pone.0017154. PMID: 21448265; PMCID: PMC3063154. 19. Puig L. Obesity and psoriasis: body weight and body mass index influence the response to biological treatment. J Eur Acad Dermatol Venereol. 2011;25(9):1007-1011. DOI: 10.1111/j.1468-3083.2011.04065.x. PMID: 21492252. 20. Gisondi P, Fostini AC, Fossà I, Girolomoni G, Targher G. Psoriasis and the metabolic syndrome. Clin Dermatol. 2018;36(1):21-28. DOI: 10.1016/j.clindermatol.2017.09.005. PMID: 29241748. 21. Guidolin L, Borin M, Fontana E, Caroppo F, Piaserico S, Fortina AB. Central Obesity in Children with Psoriasis. Acta Derm Venereol. 2018;98(2):282-283. DOI: 10.2340/00015555-2816. PMID: 29048098. 22. Rivers JP, Powell-Wiley TM, Dey AK, et al. Visceral Adiposity in Psoriasis is Associated With Vascular Inflammation by 18F-Fluorodeoxyglucose Positron-Emission Tomography/Computed Tomography Beyond Cardiometabolic Disease Risk Factors in an Observational Cohort Study. JACC Cardiovasc Imaging. 2018;11(2 Pt 2):349-357. DOI: 10.1016/j.jcmg.2017.08.014. PMID: 29055628; PMCID: PMC5803350. 23. Dattola A, Altobelli S, Marsico S, et al. Hypodermal Adipose Tissue Sonoelastography for Monitoring Treatment Response in Patients with Plaque Psoriasis. Photomed Laser Surg. 2017;35(9):484-491. DOI: 10.1089/pho.2016.4261. PMID: 28445107. 24. Mansouri B, Kivelevitch D, Natarajan B, et al. Comparison of Coronary Artery Calcium Scores Between Patients With Psoriasis and Type 2 Diabetes. JAMA Dermatol. 2016 Nov 1;152(11):1244-1253. DOI: 10.1001/jamadermatol.2016.2907. PMID: 27556410. 25. Staniak HL, Bittencourt MS, De Souza Santos I, et al. Association between psoriasis and coronary calcium score. Atherosclerosis. 2014;237(2):847-852. DOI: 10.1016/j.atherosclerosis.2014.11.004. PMID: 25463132. 26. Bissonnette R, Cademartiti F, Maffei E, Tardif JC. Increase in coronary atherosclerosis severity and the prevalence of coronary artery mixed plaques in patients with psoriasis. Br J Dermatol. 2017;176(3):800-802. DOI: 10.1111/bjd.14797. PMID: 27291937. 27. Hjuler KF, Böttcher M, Vestergaard C, et al. Increased Prevalence of Coronary Artery Disease in Severe Psoriasis and Severe Atopic Dermatitis. Am J Med. 2015;128(12):1325-34.e2. DOI: 10.1016/j.amjmed.2015.05.041. PMID: 26093174. 28. Picard D, Bénichou J, Sin C, et al. Increased prevalence of psoriasis in patients with coronary artery disease: results from a case-control study. Br J Dermatol. 2014;171(3):580-587. DOI: 10.1111/bjd.13155. PMID: 24904002. 29. Zeb I, Budoff M. Coronary artery calcium screening: does it perform better than other cardiovascular risk stratification tools? Int J Mol Sci. 2015;16(3):6606-6620. DOI: 10.3390/ijms16036606. PMID: 25807266; PMCID: PMC4394551. 30. Eckert J, Schmidt M, Magedanz A, Voigtländer T, Schmermund A. Coronary CT angiography in managing atherosclerosis. Int J Mol Sci. 2015;16(2):3740-56. DOI: 10.3390/ijms16023740. PMID: 25671814; PMCID: PMC4346923. 31. Ebrahim S, Papacosta O, Whincup P, et al. Carotid plaque, intima media thickness, cardiovascular risk factors, and prevalent cardiovascular disease in men and women: the British Regional Heart Study. Stroke. 1999;30(4):841-850. DOI: 10.1161/01.str.30.4.841. PMID: 10187889. 32. Koelemay MJ, Nederkoorn PJ, Reitsma JB, Majoie CB. Systematic review of computed tomographic angiography for assessment of carotid artery disease. Stroke. 2004;35(10):2306-2312. DOI: 10.1161/01.STR.0000141426.63959.cc. PMID: 15345798.

Send mail to Author


Send Cancel